Tag: DetermaRx
Oncocyte ties up with CORE Diagnostics to market its cancer testing...
In the United States, DetermaRx™ has rapidly gained traction, expanding to 18 sites in the first three months since commercial launch. The company is now is expanding commercial availability of DetermaRx™ to India, the Middle East and Africa..................